News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
698,611 Results
Type
Article (40433)
Company Profile (292)
Press Release (657886)
Section
Business (206489)
Career Advice (2012)
Deals (35791)
Drug Delivery (89)
Drug Development (81126)
Employer Resources (168)
FDA (16308)
Job Trends (14939)
News (348315)
Policy (32774)
Tag
Academia (2573)
Alliances (50157)
Alzheimer's disease (1307)
Approvals (16271)
Artificial intelligence (168)
Bankruptcy (358)
Best Places to Work (11666)
Biotechnology (200)
Breast cancer (206)
Cancer (1519)
Cardiovascular disease (120)
Career advice (1678)
Cell therapy (308)
Clinical research (65067)
Collaboration (564)
Compensation (304)
COVID-19 (2574)
C-suite (134)
Data (1468)
Diabetes (186)
Diagnostics (6578)
Earnings (85798)
Employer resources (146)
Events (111592)
Executive appointments (475)
FDA (17082)
Funding (515)
Gene therapy (215)
GLP-1 (619)
Government (4382)
Healthcare (18934)
Infectious disease (2671)
Inflammatory bowel disease (115)
Interviews (312)
IPO (16543)
Job creations (3686)
Job search strategy (1431)
Layoffs (427)
Legal (7921)
Lung cancer (223)
Manufacturing (215)
Medical device (13377)
Medtech (13382)
Mergers & acquisitions (19503)
Metabolic disorders (490)
Neuroscience (1669)
NextGen: Class of 2025 (6551)
Non-profit (4527)
Northern California (1862)
Obesity (280)
Opinion (186)
Parkinson's disease (106)
Patents (132)
People (57287)
Phase I (20248)
Phase II (28665)
Phase III (21344)
Pipeline (611)
Postmarket research (2565)
Preclinical (8586)
Radiopharmaceuticals (246)
Rare diseases (284)
Real estate (5986)
Regulatory (22018)
Research institute (2353)
Resumes & cover letters (351)
Southern California (1618)
Startups (3646)
United States (16659)
Vaccines (577)
Weight loss (193)
Date
Today (52)
Last 7 days (661)
Last 30 days (2007)
Last 365 days (35147)
2025 (1574)
2024 (35553)
2023 (40433)
2022 (51549)
2021 (56105)
2020 (54585)
2019 (46975)
2018 (35405)
2017 (32524)
2016 (31989)
2015 (38123)
2014 (31796)
2013 (26920)
2012 (29106)
2011 (29799)
2010 (27788)
Location
Africa (729)
Arizona (205)
Asia (38155)
Australia (6252)
California (4238)
Canada (1549)
China (359)
Colorado (190)
Connecticut (202)
Europe (82357)
Florida (595)
Georgia (152)
Illinois (418)
Indiana (241)
Maryland (682)
Massachusetts (3274)
Michigan (182)
Minnesota (322)
New Jersey (1184)
New York (1204)
North Carolina (814)
Northern California (1862)
Ohio (153)
Pennsylvania (994)
South America (1111)
Southern California (1618)
Texas (614)
Utah (121)
Washington State (434)
698,611 Results for "ariosa diagnostics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility
December 11, 2024
·
4 min read
Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21
Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that the Company has been invited to participate in the Utah booth at the FIME trade show in Miami Beach, Florida, on June 19-21.
June 18, 2024
·
1 min read
Business
Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results
Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced financial results for the quarter ended March 31, 2024.
May 9, 2024
·
10 min read
Partnered
Ending the Diagnostic Odyssey for Patients
Ending the diagnostic journey for patients, particularly those with rare diseases, improves patients’ quality of life while reducing costs to healthcare systems.
December 11, 2024
·
4 min read
·
BioSpace Insights
Press Releases
Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator (DxA) invests $10M in Alamar Biosciences, Inc. to Advance Precision Medicine in Alzheimer’s Disease
January 8, 2025
·
5 min read
Press Releases
Bracco Diagnostics Inc. Introduces Innovative “Mini” Packaging for VARIBAR® (barium sulfate), Catering to Diverse Customer Needs
December 16, 2024
·
9 min read
Press Releases
Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results
November 7, 2024
·
10 min read
Press Releases
Breath Diagnostics Inc. Appoints Aaron Roebuck as President and Closes Financing
November 1, 2024
·
4 min read
Business
Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast
Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its first quarter 2024 financial results on Thursday, May 9, 2024, after the market close.
April 25, 2024
·
1 min read
Cardio Diagnostics Holdings, Inc. to Sponsor and Showcase AI-Powered Solutions at the FLAACOs Annual Conference
November 13, 2024
·
4 min read
1 of 69,862
Next
